MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.omta.2026.201803

Медицинская библиотека · Molecular therapy. Advances · 2026

Pharmacokinetic and pharmacodynamic characterization of CD8-targeted lentiviral vector for in vivo CD19-directed CAR-T therapy.

Duback Victoria, Kharkwal Shalu S, Vagin Vasily, Paterson Kerrie, Sabbio Alicia, Kim Joohwan, Gaikwad Amey, Green Jesse, Dolinski Brian, Hlavaty Kelan, Zipp Garrett, Joyce Shannon, Koppes Abigail, Varghese Bindu, Trudeau Kyle, Shah Jagesh, Fry Terry, Elpek Kutlu G

СтатьяПеревод пока не подготовлен

Аннотация

Given challenges with access, manufacturability, and the requirement for lymphodepletion with autologous chimeric antigen receptor (CAR)-T cell therapy, a promising alternative is in vivo-mediated gene delivery using redirected viral vectors to generate tumor-antigen-specific CAR-T cells. While data supporting in vivo CAR-T cells in patients are emerging, limited studies have described the pharmacokinetics (PK) and pharmacodynamics (PD) of this approach. Here, we evaluated the PK/PD of a novel CD8-targeted lentiviral vector called "fusosome," delivering a CD19-directed CAR transgene in xenograft mouse models. In NSG mice without target cells, the fusosome vector genomes cleared rapidly from plasma (90 minutes to 2 hours) and were detectable in tested tissues for up to 1 week. We observed prolonged persistence of viral particles in peripheral blood mononuclear cell (PBMC)-engrafted mice, with vector detection peaking within 10-40 min post-administration, depending on the tissue type. CAR transgene was detectable in various lymphoid organs after 7 days post-vector dosing. Dose-dependent tumor control and specific CAR-T cell generation were observed in tumor-bearing PBMC-engrafted mice. Overall, the PK/PD of fusosome and efficacy in the tumor model supports its potential as an in vivo gene delivery approach to treat patients with B cell lymphomas.

Для цитирования: Duback Victoria, Kharkwal Shalu S, Vagin Vasily, Paterson Kerrie, Sabbio Alicia, Kim Joohwan, Gaikwad Amey, Green Jesse, Dolinski Brian, Hlavaty Kelan, Zipp Garrett, Joyce Shannon, Koppes Abigail, Varghese Bindu, Trudeau Kyle, Shah Jagesh, Fry Terry, Elpek Kutlu G. Pharmacokinetic and pharmacodynamic characterization of CD8-targeted lentiviral vector for in vivo CD19-directed CAR-T therapy.. Molecular therapy. Advances. 2026. DOI: 10.1016/j.omta.2026.201803.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.